NCT02293876 arm group 07eab5b1f994302efe78fc41f4157b1d [clinicaltrials_resource:NCT02293876/arm-group/07eab5b1f994302efe78fc41f4157b1d]
LACRIBELL® [clinicaltrials_resource:31031c02bff9cbeb90648782101ae741]Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center [clinicaltrials:NCT02293876]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02293876 arm group 07eab5b1f994302efe78fc41f4157b1d [clinicaltrials_resource:NCT02293876/arm-group/07eab5b1f994302efe78fc41f4157b1d]
Bio2RDF identifier
NCT02293876/arm-group/07eab5b1f994302efe78fc41f4157b1d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... eab5b1f994302efe78fc41f4157b1d
description [clinicaltrials_vocabulary:description]
Eye drop LACRIBELL® - two drops each eye, three times a day, after eye cleansing.
identifier
clinicaltrials_resource:NCT02293876/arm-group/07eab5b1f994302efe78fc41f4157b1d
title
NCT02293876 arm group 07eab5b1f994302efe78fc41f4157b1d
@en
type
label
NCT02293876 arm group 07eab5b1 ...... ab5b1f994302efe78fc41f4157b1d]
@en